The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 22, 2022

Filed:

Jan. 07, 2021
Applicant:

Immunogen, Inc., Waltham, MA (US);

Inventors:

Wei Li, Acton, MA (US);

Nathan Elliott Fishkin, Weymouth, MA (US);

Robert Yongxin Zhao, Lexington, MA (US);

Michael Louis Miller, Framingham, MA (US);

Ravi V. J. Chari, Newton, MA (US);

Assignee:

IMMUNOGEN, INC., Waltham, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); C07K 16/28 (2006.01); C07D 498/04 (2006.01); C07D 519/00 (2006.01); A61K 47/60 (2017.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01); A61K 45/06 (2006.01); A61K 31/5517 (2006.01); A61K 38/07 (2006.01); C07K 5/103 (2006.01); C07K 5/02 (2006.01); C07K 16/46 (2006.01); C07K 19/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2896 (2013.01); A61K 31/5517 (2013.01); A61K 38/07 (2013.01); A61K 45/06 (2013.01); A61K 47/60 (2017.08); A61K 47/6835 (2017.08); A61K 47/6849 (2017.08); A61K 47/6863 (2017.08); A61P 35/00 (2018.01); C07D 487/04 (2013.01); C07D 498/04 (2013.01); C07D 519/00 (2013.01); C07K 5/0202 (2013.01); C07K 5/1008 (2013.01); C07K 16/2803 (2013.01); C07K 16/46 (2013.01); C07K 19/00 (2013.01);
Abstract

The invention relates to novel benzodiazepine derivatives with antiproliferative activity and more specifically to novel benzodiazepines of formula (I) and (II), in which the diazepine ring (B) is fused with a heterocyclic ring (CD), wherein the heterocyclic ring is bicyclic or a compound of formula (III), in which the diazepine ring (B) is fused with a heterocyclic ring (C), wherein the heterocyclic ring is monocyclic. The invention provides cytotoxic dimers of these compounds. The invention also provides conjugates of the monomers and the dimers. The invention further provides compositions and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the compounds or conjugates of the invention. The invention further relates to methods of using the compounds or conjugates for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.


Find Patent Forward Citations

Loading…